Could Ozempic assist in weight loss, and who is eligible in Europe?

Ozempic for weight loss explained: semaglutide, GLP-1 receptor agonist, appetite regulation, BMI criteria, and prescribing standards.

In this episode, we outline how Ozempic (semaglutide) works and how doctors assess eligibility for weight management under EU medical guidance.

You’ll learn:

• What semaglutide is and how GLP-1 affects appetite and glucose control

• Approved indications for type 2 diabetes and weight management criteria

• Typical BMI thresholds (≥30, or ≥27 with weight-related conditions)

• Expected average weight reduction in clinical trials

• Common side effects: nausea, vomiting, diarrhoea, constipation

• Monitoring requirements: HbA1c, kidney function, cardiovascular risk

•  ...